Nonclinical strategy considerations for safety pharmacology: evaluation of biopharmaceuticals

Author： Vargas Hugo M Amouzadeh Hamid R Engwall Michael J

ISSN： 1474-0338

Source： Expert Opinion on Drug Safety, Vol.12, Iss.1, 2013-01, pp. : 91-102

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical Pharmacology: Special Safety Considerations in Drug Development and Pharmacovigilance

By Atuah K.N. Hughes D. Pirmohamed M.

Drug Safety, Vol. 27, Iss. 8, 2004-01 ,pp. : 535-554

Adis International

Access to resources Recommend Favorite

Current Considerations for the Effective Safety Evaluation of Drugs In Vitro

Mini Reviews in Medicinal Chemistry, Vol. 9, Iss. 7, 2009-06 ,pp. : 861-868

Bentham Science Publishers

Access to resources Recommend Favorite

Strategy to manage the treatment of severe psoriasis: considerations of efficacy, safety and cost

By Feldman Steven R Garton Rachel Averett William Balkrishnan Rajesh Vallee Jeffrey

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 9, 2003-09 ,pp. : 1525-1533

Informa Healthcare

Access to resources Recommend Favorite

Non-clinical toxicological considerations for pharmaceutical salt selection

By Thackaberry Evan A

Expert Opinion on Drug Metabolism and Toxicology, Vol. 8, Iss. 11, 2012-11 ,pp. : 1419-1433

Informa Healthcare

Access to resources Recommend Favorite

Vehicle selection for nonclinical oral safety studies

By Thackaberry Evan A

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 12, 2013-12 ,pp. : 1635-1646

Informa Healthcare

Access to resources Recommend Favorite